Skip to main content

Table 2 ECT2 expression is an independent prognostic factor for breast cancer patients (HBreD145Su01)

From: Increased expression of ECT2 predicts the poor prognosis of breast cancer patients

Variables

Univariate analysis

Variable selection

HR (95%CI)

P Value

HR (95%CI)

P value

Age

0.998 (0.970–1.027)

0.895

  

Tumor location (left vs. right)

2.077 (0.930–4.638)

0.074

  

Grade (grade 2 vs. 1)

1.575 (0.620–3.999)

0.339

  

TNM stage (III–IV vs. I–II)

1.979 (0.988–3.966)

0.054

  

ER (ER+ vs. ER−)

0.348 (0.157–0.768)

0.009

0.414 (0.185–0.927)

0.032

PR (PR+ vs. PR−)

0.385 (0.173–0.858)

0.020

  

Her2 (Her2+ vs. Her2−)

0.906 (0.338–2.428)

0.845

  

ECT2 level (high vs. low)

6.198 (2.129–18.043)

0.0001

4.899 (1.668–14.385)

0.004